Update on Streptococcus suis Research and Prevention in the Era of Antimicrobial Restriction: 4th International Workshop on S. suis.
View / Open Files
Authors
Segura, Mariela
Brockmeier, Susan L
Greeff, Astrid de
Okura, Masatoshi
Saléry, Mariette
Schultsz, Constance
Valentin-Weigand, Peter
Wells, Jeremy
Gottschalk, Marcelo
Publication Date
2020-05-14Journal Title
Pathogens
ISSN
2076-0817
Publisher
MDPI AG
Volume
9
Issue
5
Language
eng
Type
Article
This Version
VoR
Physical Medium
Electronic
Metadata
Show full item recordCitation
Segura, M., Aragon, V., Brockmeier, S. L., Gebhart, C., Greeff, A. d., Kerdsin, A., O'Dea, M. A., et al. (2020). Update on Streptococcus suis Research and Prevention in the Era of Antimicrobial Restriction: 4th International Workshop on S. suis.. Pathogens, 9 (5) https://doi.org/10.3390/pathogens9050374
Abstract
Streptococcus suis is a swine pathogen and a zoonotic agent afflicting people in close contact with infected pigs or pork meat. Sporadic cases of human infections have been reported worldwide. In addition, S. suis outbreaks emerged in Asia, making this bacterium a primary health concern in this part of the globe. In pigs, S. suis disease results in decreased performance and increased mortality, which have a significant economic impact on swine production worldwide. Facing the new regulations in preventive use of antimicrobials in livestock and lack of effective vaccines, control of S. suis infections is worrisome. Increasing and sharing of knowledge on this pathogen is of utmost importance. As such, the pathogenesis and epidemiology of the infection, antimicrobial resistance, progress on diagnosis, prevention, and control were among the topics discussed during the 4th International Workshop on Streptococcus suis (held in Montreal, Canada, June 2019). This review gathers together recent findings on this important pathogen from lectures performed by lead researchers from several countries including Australia, Canada, France, Germany, Japan, Spain, Thailand, The Netherlands, UK, and USA. Finally, policies and recommendations for the manufacture, quality control, and use of inactivated autogenous vaccines are addressed to advance this important field in veterinary medicine.
Sponsorship
Wellcome Trust (109385/Z/15/Z)
Royal Society (CH160114)
Isaac Newton Trust (MINUTE 17.24(u))
European Commission Horizon 2020 (H2020) Societal Challenges (727966)
Medical Research Council (MR/P007597/1)
Identifiers
External DOI: https://doi.org/10.3390/pathogens9050374
This record's URL: https://www.repository.cam.ac.uk/handle/1810/308957
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.